268 related articles for article (PubMed ID: 9042333)
1. A possible dual physiological role of extracellular ATP in the modulation of platelet aggregation.
Soslau G; Youngprapakorn D
Biochim Biophys Acta; 1997 Feb; 1355(2):131-40. PubMed ID: 9042333
[TBL] [Abstract][Full Text] [Related]
2. Extracellular ATP inhibits agonist-induced mobilization of internal calcium in human platelets.
Soslau G; McKenzie RJ; Brodsky I; Devlin TM
Biochim Biophys Acta; 1995 Jul; 1268(1):73-80. PubMed ID: 7626665
[TBL] [Abstract][Full Text] [Related]
3. Aggregation of human and canine platelets: modulation by purine nucleotides.
Soslau G; Arabe L; Parker J; Pelleg A
Thromb Res; 1993 Oct; 72(2):127-37. PubMed ID: 8303650
[TBL] [Abstract][Full Text] [Related]
4. Occupancy of P2 purinoceptors with unique properties modulates the function of human platelets.
Soslau G; Brodsky I; Parker J
Biochim Biophys Acta; 1993 Jun; 1177(2):199-207. PubMed ID: 7684612
[TBL] [Abstract][Full Text] [Related]
5. Combined administration of 5-HT2 and thromboxane A2 antagonists: effects on platelet aggregation and isolated cardiac muscle.
Shaw LA; Batey AJ; Coker SJ
Br J Pharmacol; 1997 Jul; 121(5):875-82. PubMed ID: 9222543
[TBL] [Abstract][Full Text] [Related]
6. Studies on the effects of agonists and antagonists on platelet shape change and platelet aggregation in whole blood.
Sanderson HM; Heptinstall S; Vickers J; Lösche W
Blood Coagul Fibrinolysis; 1996 Mar; 7(2):245-8. PubMed ID: 8735830
[TBL] [Abstract][Full Text] [Related]
7. Effects of the P2-purinoceptor antagonist, suramin, on human platelet aggregation induced by adenosine 5'-diphosphate.
Hourani SM; Hall DA; Nieman CJ
Br J Pharmacol; 1992 Feb; 105(2):453-7. PubMed ID: 1559134
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of ADP-induced platelet activation by 7-chloro-4-nitrobenz-2-oxa-1,3-diazole: covalent modification of aggregin, a putative ADP receptor.
Puri RN; Colman RW
J Cell Biochem; 1996 Apr; 61(1):97-108. PubMed ID: 8726359
[TBL] [Abstract][Full Text] [Related]
9. Antithrombotic effects of peroxynitrite: inhibition and reversal of aggregation in human platelets.
Yin K; Lai PS; Rodriguez A; Spur BW; Wong PY
Prostaglandins; 1995 Sep; 50(3):169-78. PubMed ID: 8750213
[TBL] [Abstract][Full Text] [Related]
10. Influence of vortex speed on fresh versus stored platelet aggregation in the absence and presence of extracellular ATP.
Soslau G; Schechner AJ; Alcasid PJ; Class R
Thromb Res; 2000 Jan; 97(2):15-27. PubMed ID: 10688331
[TBL] [Abstract][Full Text] [Related]
11. Alteration of release and role of adenosine diphosphate and thromboxane A2 during collagen-induced aggregation of platelets from cattle with Chediak-Higashi syndrome.
Honda N; Ohnishi K; Fujishiro T; Ikeda M; Ito K
Am J Vet Res; 2007 Dec; 68(12):1399-406. PubMed ID: 18052747
[TBL] [Abstract][Full Text] [Related]
12. An inhibitor of collagen-induced platelet aggregation from the saliva of Triatoma pallidipennis.
Noeske-Jungblut C; Krätzschmar J; Haendler B; Alagon A; Possani L; Verhallen P; Donner P; Schleuning WD
J Biol Chem; 1994 Feb; 269(7):5050-3. PubMed ID: 8106481
[TBL] [Abstract][Full Text] [Related]
13. Antiaggregatory activity of 8-epi-prostaglandin F2 alpha and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets.
Yin K; Halushka PV; Yan YT; Wong PY
J Pharmacol Exp Ther; 1994 Sep; 270(3):1192-6. PubMed ID: 7932171
[TBL] [Abstract][Full Text] [Related]
14. Antiplatelet actions of 2-(4-[1-(2-chlorophenyl) piperazinyl]) methyl-2,3-dihydroimidazo[1,2-c]quinazolin-5(6H)-one compound.
Ding YA; Chou TC; Chern JW; Yen MH
Thromb Res; 1995 Feb; 77(3):291-303. PubMed ID: 7740521
[TBL] [Abstract][Full Text] [Related]
15. Rat platelet aggregation by ATP. Aggregometrical and ultrastructural comparison with aggregations induced by ADP and collagen.
Ts'ao C
Am J Pathol; 1976 Dec; 85(3):581-94. PubMed ID: 998732
[TBL] [Abstract][Full Text] [Related]
16. Phenol red is a thromboxane A2/prostaglandin H2 receptor antagonist in canine lingual arteries and human platelets.
Greenberg SS; Johns A; Kleha J; Xie J; Wang Y; Bianchi J; Conley K
J Pharmacol Exp Ther; 1994 Mar; 268(3):1352-61. PubMed ID: 8138950
[TBL] [Abstract][Full Text] [Related]
17. Secreted ADP plays a central role in thrombin-induced phospholipase D activation in human platelets.
Martinson EA; Scheible S; Marx-Grunwitz A; Presek P
Thromb Haemost; 1998 Dec; 80(6):976-81. PubMed ID: 9869170
[TBL] [Abstract][Full Text] [Related]
18. Role for p38 mitogen-activated protein kinase in platelet aggregation caused by collagen or a thromboxane analogue.
Saklatvala J; Rawlinson L; Waller RJ; Sarsfield S; Lee JC; Morton LF; Barnes MJ; Farndale RW
J Biol Chem; 1996 Mar; 271(12):6586-9. PubMed ID: 8636072
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic and pharmacodynamic profiles of vapiprost, a selective, long-lasting thromboxane receptor antagonist, after single and multiple oral administration to healthy volunteers.
Uematsu T; Nagashima S; Mizuno A; Hirano K; Nakashima M
J Clin Pharmacol; 1991 Sep; 31(9):815-22. PubMed ID: 1839540
[TBL] [Abstract][Full Text] [Related]
20. A possible role for extracellular bicarbonate in U-46619-induced rat platelet aggregation.
Yokoyama K; Kudo I; Nakamura H; Inoue K
Thromb Res; 1994 May; 74(4):369-76. PubMed ID: 8085238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]